Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Divo, C. Cote, J. P. De Torres, C. Casanova, J. M. Marin, V. Pinto-Plata, J. Zulueta, C. Cabrera, J. Zagaceta, B. Celli (Boston, Bay Pines, United States Of America; Pamplona, Zaragoza, Tenerife, Palmas de Gran Canaria, Spain). Development and validation of a new comorbidity index for COPD. Eur Respir J 2011; 38: Suppl. 55, 1755

Member's Comments

No comment yet.

Related content which might interest you: BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014 Measurement of COPD severity: development and validation of a survey-based instrument Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Measurement of COPD severity: further validation of a survey-based instrument Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017 Multidimensional system for assessment of COPD patients. Comparison with BODE index Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 COPD staging systems and BODE index Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Application of the COMCOLD comorbidity index to a UK primary care COPD cohort Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Is it possible to improve the prediction ability of the BODE index? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Validation of bode index as a predictor of mortality in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Newly developed simple QoL questionnaire in early detection of COPD in a population of smokers at risk for COPD development Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Can we assess COPD comorbidities by BODE index? Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 The value of short physical performance battery (SPPB) as an alternative component of the BODE Index in predicting death in chronic obstructive pulmonary disease (COPD) in the ERICA cohort. Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 The new prognostic multidimensional index HODEH in patient with COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 A multimarker approach to identify atherosclerosis in COPD Source: International Congress 2014 – Markers Year: 2014 Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index Source: Eur Respir J 2014; 43: 397-408 Year: 2013